{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-005788","form_type":"8-K","ticker":"NUVB","cik":"0001811063","company_name":"Nuvation Bio Inc.","filed_at":"2022-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.351652+00:00","generated_at":"2026-06-27T19:33:55.474675+00:00","sec_items":["2.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nuvation Bio reports estimated cash of $765M as of Dec. 31, 2021","bullets":["Estimated cash, cash equivalents, and marketable securities of $765M as of December 31, 2021.","Announcement made via Form 8-K on January 10, 2022.","No other financial results or forward guidance provided in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-005788","json":"https://secwatch.observer/filing/0001193125-22-005788.json","markdown":"https://secwatch.observer/filing/0001193125-22-005788.md","text":"https://secwatch.observer/filing/0001193125-22-005788.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811063/000119312522005788/0001193125-22-005788-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811063/000119312522005788/d276640d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T19:33:55.474675+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}